christoph
grace
md
facp
chapter
influenza
respiratori
ill
caus
rna
viru
come
two
form
influenza
influenza
b
although
gener
selflimit
influenza
caus
signific
morbid
mortal
especi
risk
see
answer
influenza
common
fall
winter
month
increas
indoor
crowd
low
humid
though
ill
continu
april
may
northern
hemispher
influenza
describ
surfac
glycoprotein
hemagglutinin
h
neuraminidas
n
hemagglutinin
structur
differ
type
allow
attach
host
respiratori
epithelium
neuraminidas
nine
differ
type
act
enzym
facilit
releas
newli
replic
virus
infect
cell
human
often
infect
influenza
virus
h
n
terminolog
also
use
name
influenza
strain
spread
yearli
gener
year
one
two
influenza
strain
influenza
b
strain
circul
season
circul
strain
includ
influenza
b
influenza
character
abrupt
onset
fever
nonproduct
cough
sore
throat
rhiniti
headach
myalgia
fatigu
children
may
also
otiti
media
symptom
gener
resolv
within
day
though
cough
may
persist
sever
week
flu
season
otherwis
healthi
adult
fever
cough
chanc
influenza
simpl
case
definit
though
may
accur
diagnos
influenza
young
children
elderli
comorbid
cardiopulmonari
ill
risk
sever
complic
influenza
center
diseas
control
prevent
cdc
warn
influenza
especi
seriou
life
threaten
patient
risk
factor
follow
n
age
month
year
n
age
year
older
n
chronic
pulmonari
includ
asthma
cardiovascular
except
hypertens
renal
hepat
neurolog
hematolog
metabol
disord
includ
diabet
mellitu
n
immunosuppress
caus
medic
organ
transplant
malign
hiv
n
pregnanc
influenza
season
n
age
month
year
receiv
longterm
aspirin
therapi
rey
syndrom
n
resid
nurs
home
longtermcar
facil
n
american
indian
alaska
nativ
n
morbidli
obes
bodi
mass
index
greater
accord
cdc
averag
excess
death
hospit
attribut
influenza
yearli
flu
season
influenza
caus
primari
viral
hemorrhag
pneumonia
character
progress
dyspnea
leukocytosi
potenti
progress
respiratori
failur
acut
respiratori
diseas
syndrom
secondari
bacteri
pneumonia
may
develop
older
patient
chronic
cardiopulmonari
ill
period
improv
patient
appear
worsen
sign
symptom
bacteri
pneumonia
often
caus
streptococcu
pneumonia
haemophilu
influenza
staphylococcu
aureu
addit
patient
may
exacerb
chronic
cardiopulmonari
ill
lesscommon
complic
includ
myositi
myocard
pericard
enceph
toxic
shocklik
ill
syndrom
rey
syndrom
symptom
influenza
nonspecif
caus
larg
array
virus
bacteria
pathogen
caus
ill
similar
influenza
febril
respiratori
ill
may
refer
influenzalik
ill
ili
caus
ili
addit
influenza
includ
respiratori
syncyti
viru
parainfluenza
rhinoviru
coronaviru
agent
common
cold
adenoviru
metapneumoviru
group
streptococcu
mycoplasma
chlamydia
bordetella
pertussi
influenza
often
clinic
diagnosi
without
risk
complic
requir
hospit
diagnost
requir
accur
way
confirm
patient
influenza
obtain
nasopharyng
swab
swab
one
use
collect
transport
bacteri
cultur
sampl
swab
need
insert
nose
pharynx
test
polymeras
chain
reaction
pcr
accur
test
rapid
influenza
diagnost
test
ridt
sensit
reason
specif
neg
ridt
help
posit
ridt
help
peopl
posit
ridt
influenza
approach
patient
ili
progress
stepwis
manner
patient
assess
degre
ill
presenc
risk
factor
complic
mild
symptom
short
breath
abl
maintain
hydrat
risk
complic
need
test
treat
symptomat
moder
symptom
short
breath
difficulti
maintain
hydrat
sign
symptom
pneumonia
test
treat
antivir
medic
sever
symptom
respiratori
distress
alter
mental
statu
need
immedi
assess
emerg
depart
pregnant
women
influenza
especi
third
trimest
high
rate
complic
urgent
assess
emerg
depart
also
see
figur
channel
blocker
amantadin
rimantadin
often
use
emerg
resist
central
nervou
system
toxic
neuraminidas
inhibitor
oseltamivir
zanamivir
act
block
surfac
neuraminidas
activ
influenza
b
oseltamivir
oral
dose
mg
twice
daili
day
treatment
zanamivir
nasal
spray
approv
person
age
year
agent
shown
shorten
durat
influenza
symptom
modestli
start
within
hour
symptom
durat
ill
may
decreas
approxim
day
sever
intraven
iv
formul
research
iv
zanamivir
peramivir
may
use
critic
ill
person
unabl
use
absorb
convent
agent
manag
patient
admit
hospit
ili
patient
ili
fallwint
flu
season
admit
hospit
presum
influenza
rule
nasopharyng
pcr
test
result
back
n
isol
privat
room
n
standard
droplet
precaut
use
n
treat
neuraminidas
inhibitor
consider
given
treat
antibiot
ceftriaxon
vancomycin
cover
potenti
streptococc
staphylococc
haemophilu
superinfect
nasopharyng
pcr
return
neg
influenza
treatment
isol
stop
keep
mind
neg
ridt
rule
influenza
hemagglutinin
h
neuraminidas
n
undergo
small
chang
structur
call
antigen
drift
yearli
basi
allow
viru
partial
evad
human
past
immun
respons
caus
yearli
epidem
larger
chang
h
n
call
antigen
shift
occur
infrequ
antigen
shift
occur
much
popul
essenti
limit
immun
new
strain
pandem
may
occur
seen
pandem
refer
new
viral
type
worldwid
spread
sever
pandem
sever
caus
estim
million
death
worldwid
wherea
pandem
sever
usual
epidem
year
though
disproportion
affect
younger
adult
children
viral
strain
affect
predomin
bird
includ
aquat
fowl
domest
poultri
refer
bird
flu
gener
infect
human
pandem
influenza
season
larg
chang
h
n
structur
occur
leav
much
popul
especi
younger
year
old
inadequ
immun
new
structur
result
reassort
bird
swine
human
influenza
strain
result
antigen
new
strain
appear
start
simultan
southern
california
mexico
spring
spread
rapidli
worldwid
world
health
organ
declar
pandem
june
young
adult
children
particularli
affect
argentina
exampl
pediatr
hospit
rate
doubl
hospit
children
admit
intens
care
unit
icu
requir
mechan
ventil
die
unit
state
patient
admit
hospit
age
year
seventythre
percent
patient
least
one
underli
condit
includ
asthma
diabet
heart
lung
neurolog
diseas
pregnanc
sever
pandem
fortun
pandem
mild
pandem
compar
sever
estim
similar
pandem
mani
countri
includ
australia
spain
unit
state
report
icu
admiss
patient
requir
mechan
ventil
death
admit
icu
often
extens
multifoc
pneumonia
chest
radiograph
one
studi
admit
icu
pulmonari
emboli
chest
comput
tomographi
earli
pandem
spain
note
patient
admit
icu
primari
viral
pneumonia
multiorgan
failur
requir
mechan
ventil
need
renal
replac
therapi
australia
new
zealand
experi
one
third
patient
receiv
mechan
ventil
treat
extracorpor
membran
oxygen
ecmo
die
canadian
experi
critic
ill
patient
receiv
mechan
ventil
median
day
mortal
patient
lung
rescu
therapi
includ
neuromuscular
blockad
inhal
nitrou
oxid
highfrequ
oscillatori
ventil
ecmo
proneposit
ventil
mortal
patient
admit
icu
manag
patient
admit
icu
respiratori
ill
influenza
season
presum
influenza
prove
otherwis
nasopharyng
swab
pcr
patient
may
seen
exacerb
underli
cardiopulmonari
diseas
primari
viral
pneumonia
secondari
bacteri
pneumonia
patient
given
treatment
neuraminidas
inhibitor
antibiot
antibacteri
therapi
direct
primarili
pneumonia
aureu
h
influenza
possibl
initi
regimen
may
includ
ceftriaxon
vancomycin
respiratori
blood
cultur
result
known
empir
antibiot
narrow
stop
influenza
often
spread
largeparticl
respiratori
droplet
creat
patient
cough
sneez
mode
transmiss
gener
requir
close
contact
feet
larger
heavier
respiratori
particl
quickli
fall
air
hand
contact
environment
surfac
contamin
viru
also
transmit
influenza
hand
come
contact
mucos
surfac
touch
eye
nose
mouth
concern
express
influenza
may
airborn
transmit
smallparticl
aerosol
though
clear
much
mode
transmiss
contribut
commun
spread
offic
hospit
cdc
recommend
standard
droplet
precaut
follow
n
place
patient
privat
room
n
wear
surgic
mask
enter
patient
room
n
wear
glove
gown
expect
contact
patient
blood
bodi
fluid
secret
includ
respiratori
n
particip
aerosolgener
procedur
intub
extub
bronchoscopi
autopsi
fittest
respir
power
airpurifi
respir
papr
worn
health
care
worker
need
practic
good
hand
hygien
patient
contact
cdc
recommend
person
older
month
get
yearli
vaccin
especi
true
high
risk
complic
influenza
outlin
earlier
subcutan
inject
form
use
inactiv
hemagglutinin
antigen
three
circul
vaccin
strain
year
age
good
health
pregnant
nasal
aerosol
live
attenu
virus
avail
form
safe
effect
children
adult
younger
year
approxim
develop
protect
level
antibodi
though
may
less
effect
elderli
immun
compromis
health
care
worker
need
vaccin
yearli
remain
healthi
risk
spread
influenza
vulner
patient
